TRULIGN TORIC POSTERIOR CHAMBER INTRAOCULAR LENS

FDA Premarket Approval P030002 S027

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the trulign toric posterior chamber intraocular lens (models: at50t, bl1at and bl1ut) and trulign toric calculator. This device is indicated for primary implantation in the capsular bag of the eye for the visual correction of aphakia and postoperative refractive astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia who desire reduction of residual refractive cylinder with increased spectacle independence andimproved uncorrected near, intermediate and distance vision.

DeviceTRULIGN TORIC POSTERIOR CHAMBER INTRAOCULAR LENS
Generic NameLens, Intraocular, Toric Optics
ApplicantBausch & Lomb, Inc.
Date Received2012-03-27
Decision Date2013-05-20
Notice Date2013-06-18
PMAP030002
SupplementS027
Product CodeMJP 
Docket Number13M-0724
Advisory CommitteeOphthalmic
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address Bausch & Lomb, Inc. 50 Technology Drive irvine, CA 92618
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P030002Original Filing
S040 2021-12-22 30-day Notice
S039
S038 2016-02-01 Normal 180 Day Track
S037 2015-12-18 Normal 180 Day Track No User Fee
S036 2015-12-15 Real-time Process
S035 2015-07-02 Normal 180 Day Track No User Fee
S034 2015-04-01 Normal 180 Day Track No User Fee
S033 2015-01-26 Real-time Process
S032 2014-11-13 30-day Notice
S031 2014-04-14 30-day Notice
S030 2014-02-24 30-day Notice
S029 2014-01-16 30-day Notice
S028 2013-06-18 Normal 180 Day Track No User Fee
S027 2012-03-27 Panel Track
S026
S025 2011-08-18 30-day Notice
S024 2011-07-14 Real-time Process
S023 2011-02-24 30-day Notice
S022 2010-03-08 Real-time Process
S021 2009-08-26 Real-time Process
S020 2009-06-02 Normal 180 Day Track
S019 2009-05-01 Real-time Process
S018 2009-01-27 30-day Notice
S017 2008-08-07 30-day Notice
S016 2008-06-17 30-day Notice
S015 2008-05-15 Normal 180 Day Track No User Fee
S014 2007-12-17 Normal 180 Day Track
S013 2007-11-05 Real-time Process
S012 2007-08-28 30-day Notice
S011 2007-04-25 30-day Notice
S010 2007-04-06 Real-time Process
S009 2007-03-05 Real-time Process
S008 2006-07-24 Normal 180 Day Track No User Fee
S007
S006 2005-10-20 Normal 180 Day Track No User Fee
S005 2005-08-23 Special (immediate Track)
S004 2005-07-05 Real-time Process
S003 2005-05-04 Normal 180 Day Track No User Fee
S002 2004-08-30 Special (immediate Track)
S001 2004-06-28 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.